Endocrinology
News
First-of-its kind guideline on lipid monitoring in endocrine diseases
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond...
News
Consensus guidelines address inpatient diabetes technology
The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin...
News
Vertebral fractures in COVID-19 linked to mortality
Radiologic thoracic vertebral fractures were found in one-third of COVID-19 patients who underwent lateral chest x-rays, and those patients were...
Clinical
No mortality benefit after intensive glucose control once Hb A1c curves equalize
Is there a reduction in cardiovascular events in veterans with type 2 diabetes who were treated with intensive glucose control versus standard...
News
COVID-19 antibody response not reduced with diabetes
Findings provide “cautious optimism” that a COVID-19 vaccine would be expected to work as well in people with diabetes as those without.
News
Entresto halves renal events in preserved EF heart failure patients
The PARAGON-HF trial of sacubitril/valsartan in patients with heart failure with preserved ejection fraction didn’t meet its primary outcome but...
News
Empagliflozin cut PA pressures in heart failure patients
The drops in pulmonary artery pressure were modest but large enough to be clinically meaningful, they appeared quickly, and increased over time....
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan
News
Dapagliflozin’s CKD performance sends heart failure messages
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians...
News
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against...